Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients

被引：0
|
作者：
Gervasini, G.
García-Martín, E.
Ladero, J. M.
Pizarro, R.
Sastre, J.
Martínez, C.
García, M.
Díaz-Rubio, M.
Agúndez, J. A. G.
机构：
[1] Univ Extremadura, Dept Pharmacol & Psychiat, E-06071 Badajoz, Spain
[2] Univ Extremadura, Dept Biochem & Mol Biol & Genet, E-06071 Badajoz, Spain
[3] Univ Complutense Madrid, Hosp Clin Carlos, Gastroenterol Serv, Madrid, Spain
[4] Univ Complutense Madrid, Hosp Clin Carlos, Serv Oncol, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2006年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [1] Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients
    Gervasini, Guillermo
    Garcia-Martin, Elena
    Ladero, Jose M.
    Pizarro, Rosa
    Sastre, Javier
    Martinez, Carmen
    Garcia, Monserrat
    Diaz-Rubio, Manuel
    Agundez, Jose A. G.
    BMC CANCER, 2007, 7 (1)
  • [2] Genetic variability in CYP3A4 and CYP3A5in primary liver, gastric and colorectal cancer patients
    Guillermo Gervasini
    Elena García-Martín
    José M Ladero
    Rosa Pizarro
    Javier Sastre
    Carmen Martínez
    Monserrat García
    Manuel Diaz-Rubio
    José AG Agúndez
    BMC Cancer, 7
  • [3] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06): : 479 - 484
  • [4] CYP3A4 and CYP3A5 genotyping by pyrosequencing
    Garsa, AA
    McLeod, HL
    Marsh, S
    BMC MEDICAL GENETICS, 2005, 6
  • [5] Genetic variability of CYP2D6, CYP3A4 and CYP3A5 among the Egyptian population
    Mutawi, Thuraya M.
    Zedan, Mohamed M.
    Yahya, Raida S.
    Zakria, Mahmoud M.
    El-Sawi, Mamdouh R.
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2021, 22 (06) : 323 - 334
  • [6] Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer
    Bellah, Sm Faysal
    Salam, Md. Abdus
    Billah, S. M. Saker
    Karim, Md Rezaul
    ANNALS OF HUMAN BIOLOGY, 2023, 50 (01) : 63 - 74
  • [7] Genetic Variants of CYP3A4 and CYP3A5 in Cynomolgus and Rhesus Macaques
    Uno, Yasuhiro
    Matsushita, Akinori
    Osada, Naoki
    Uehara, Shotaro
    Kohara, Sakae
    Nagata, Ryoichi
    Fukuzaki, Koichiro
    Utoh, Masahiro
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (02) : 209 - 214
  • [8] The evaluation of CYP3A4 and CYP3A5 genetic profiles in Turkish population
    Arici, Merve
    Ozhan, Gul
    ISTANBUL JOURNAL OF PHARMACY, 2016, 46 (01): : 15 - 22
  • [9] CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer
    Plummer, SJ
    Conti, DV
    Paris, PL
    Curran, AP
    Casey, G
    Witte, JS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (09) : 928 - 932
  • [10] Comparative drug metabolism by CYP3A4 and CYP3A5
    Huang, WL
    Lin, YS
    Dai, Y
    Totah, RA
    Calamia, JC
    Thummel, KE
    DRUG METABOLISM REVIEWS, 2003, 35 : 187 - 187
12345